Kurganpribor, LRS Engineering Team Up to Manufacture Coronary Stents

| By | Medical Devices Manufacturing, Russian Pharma

Kurganpribor, LRS Engineering Team up to manufacture coronary stents. NPO Kurganpribor, a joint-stock company based in Kurgan, and Germany’s LRS Engineering have signed a cooperation agreement to make coronary stents.

We will be quick enough to launch the project, but our products will enter the market no earlier than in two to three years’ time, the Russian company’s press service reported, citing Kurganpribor General Director Fyodor Kolosovnikov.

Our products will have to be put through a certification and legalization procedure on the market of medical technologies. Our nearest plan is to make 50,000 stents, annually. With this production capacity production is expected to increase at an annual rate of 500 million rubles,

he said.

LRS Engineering will make production technology available to Kurganpribor and help the Russian company to buy equipment, the press service said.

The production facility to be launched will make orthopedic and coronary medical devices. Technological backup is of great importance. The German company will develop and design these medical devices, LRS Engineering spokesman Vladimir Sergunin said.

Coronary stent is a medical device used to treat the ischemic disease of the heart. About 450,000 coronary stents are implanted in Russia each year and only 50,000 of them are domestically manufactured in Novosibirsk and Penza.

NPO Kurganpribor makes instruments and adaptors for military and civilian uses. Financial Innovations LLC holds at 100% stake in Kurganpribor, according to the SPARK-Interfax database. Sergei and Svetlana Muratov indirectly co-own the company on a parity basis.

SOURCE: interfax.ru
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.